BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37730533)

  • 1. Network meta-analysis of adjuvant treatments for patients with hepatocellular carcinoma after curative resection.
    Ye Y; Wang Y; Xu H; Yi F
    BMC Gastroenterol; 2023 Sep; 23(1):320. PubMed ID: 37730533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different adjuvant therapy regimen efficacies in patients with high risk of recurrence after radical resection of hepatocellular carcinoma.
    Feng X; Feng GY; Tao J; Ao YP; Wu XH; Qi SG; Shi ZR
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10505-10518. PubMed ID: 37284841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Qi X; Liu L; Wang D; Li H; Su C; Guo X
    Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
    Chen ZH; Zhang XP; Zhou TF; Wang K; Wang H; Chai ZT; Shi J; Guo WX; Cheng SQ
    Eur J Surg Oncol; 2019 Nov; 45(11):2188-2196. PubMed ID: 31256949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis.
    Liao M; Zhu Z; Wang H; Huang J
    Scand J Gastroenterol; 2017; 52(6-7):624-634. PubMed ID: 28276833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
    Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
    Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Qi X; Wang D; Su C; Li H; Guo X
    Oncotarget; 2015 Jul; 6(21):18715-33. PubMed ID: 26243835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies.
    Marelli L; Stigliano R; Triantos C; Senzolo M; Cholongitas E; Davies N; Yu D; Meyer T; Patch DW; Burroughs AK
    Cancer Treat Rev; 2006 Dec; 32(8):594-606. PubMed ID: 17045407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.
    Katsanos K; Kitrou P; Spiliopoulos S; Maroulis I; Petsas T; Karnabatidis D
    PLoS One; 2017; 12(9):e0184597. PubMed ID: 28934265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Efficacy and Safety of Dendritic Cells Co-Cultured with Cytokine-Induced Killer Cell Therapy in Combination with TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma: a Meta-Analysis.
    Su Y; Yang Y; Ma Y; Zhang Y; Rao W; Yang G; Kou C
    Clin Lab; 2016; 62(4):599-608. PubMed ID: 27215078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis.
    Roccarina D; Majumdar A; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011649. PubMed ID: 28281295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of transarterial therapy combined with first-line tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a network meta-analysis.
    Hu L; Lin J; Shi X; Wang A
    World J Surg Oncol; 2023 Jul; 21(1):208. PubMed ID: 37475030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resection Plus Post-operative Adjuvant Transcatheter Arterial Chemoembolization (TACE) Compared with Resection Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Huo YR; Chan MV; Chan C
    Cardiovasc Intervent Radiol; 2020 Apr; 43(4):572-586. PubMed ID: 31897617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of transarterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis.
    Leng JJ; Xu YZ; Dong JH
    ANZ J Surg; 2016 Oct; 86(10):816-820. PubMed ID: 25088384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
    Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
    Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
    World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of cytokine-induced killer cells therapy in combination with minimally invasive treatment for hepatocellular carcinoma.
    Li X; Dai D; Song X; Liu J; Zhu L; Xu W
    Clin Res Hepatol Gastroenterol; 2014 Oct; 38(5):583-91. PubMed ID: 24924902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness of Adjuvant Treatment for Resected Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis.
    Liu Y; Wang Y; Guo X; He Y; Zhou J; Lv Q; Huang X; Li X
    Front Oncol; 2021; 11():709278. PubMed ID: 34540675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of treatment regimens for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.
    Chen QF; Wu PH; Huang T; Shen LJ; Huang ZL; Li W
    Medicine (Baltimore); 2019 Oct; 98(40):e17460. PubMed ID: 31577775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.